Enovis Corporation (ENOV) DCF Valuation

Enovis Corporation (ENOV) DCF Valoración

US | Industrials | Industrial - Machinery | NYSE
Enovis Corporation (ENOV) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Enovis Corporation (ENOV) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¿Busca evaluar el valor intrínseco de Enovis Corporation? Nuestra calculadora de DCF ENOV integra datos del mundo real con características integrales de personalización, lo que le permite refinar sus pronósticos y mejorar sus estrategias de inversión.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 3,327.5 3,070.8 3,854.3 1,563.1 1,707.2 1,568.8 1,441.6 1,324.8 1,217.4 1,118.7
Revenue Growth, % 0 -7.71 25.52 -59.45 9.22 -8.11 -8.11 -8.11 -8.11 -8.11
EBITDA 409.2 180.0 95.0 225.8 169.9 141.3 129.8 119.3 109.6 100.7
EBITDA, % 12.3 5.86 2.47 14.44 9.95 9 9 9 9 9
Depreciation 236.0 246.2 187.0 202.9 217.1 143.3 131.7 121.0 111.2 102.2
Depreciation, % 7.09 8.02 4.85 12.98 12.72 9.13 9.13 9.13 9.13 9.13
EBIT 173.2 -66.2 -92.0 22.9 -47.2 -2.0 -1.8 -1.7 -1.5 -1.4
EBIT, % 5.21 -2.16 -2.39 1.46 -2.76 -0.12718 -0.12718 -0.12718 -0.12718 -0.12718
Total Cash 109.6 97.1 719.4 24.3 36.2 90.3 83.0 76.3 70.1 64.4
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 561.9 517.0 255.0 267.4 291.5
Account Receivables, % 16.89 16.84 6.61 17.11 17.07
Inventories 571.6 564.8 776.3 426.6 468.8 346.6 318.5 292.7 269.0 247.2
Inventories, % 17.18 18.39 20.14 27.29 27.46 22.09 22.09 22.09 22.09 22.09
Accounts Payable 359.8 330.3 155.2 135.6 132.5 131.9 121.2 111.4 102.3 94.0
Accounts Payable, % 10.81 10.75 4.03 8.68 7.76 8.41 8.41 8.41 8.41 8.41
Capital Expenditure -125.4 -114.8 -104.2 -105.5 -122.2 -75.7 -69.5 -63.9 -58.7 -54.0
Capital Expenditure, % -3.77 -3.74 -2.7 -6.75 -7.16 -4.82 -4.82 -4.82 -4.82 -4.82
Tax Rate, % 50.45 50.45 50.45 50.45 50.45 50.45 50.45 50.45 50.45 50.45
EBITAT 64.7 -73.1 -54.9 422.4 -23.4 -1.4 -1.3 -1.2 -1.1 -1.0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -598.3 80.4 -96.6 837.5 2.1 245.5 97.2 89.3 82.1 75.4
WACC, % 11.65 12.16 11.84 12.16 11.75 11.91 11.91 11.91 11.91 11.91
PV UFCF
SUM PV UFCF 456.0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 77
Terminal Value 776
Present Terminal Value 442
Enterprise Value 898
Net Debt 500
Equity Value 398
Diluted Shares Outstanding, MM 54
Equity Value Per Share 7.30

What You Will Receive

  • Comprehensive Financial Model: Enovis Corporation’s actual data facilitates accurate DCF valuation.
  • Complete Forecast Flexibility: Modify revenue growth, profit margins, WACC, and other essential factors.
  • Real-Time Calculations: Automatic updates allow you to view results instantly as adjustments are made.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation outputs.
  • Adaptable and Repeatable: Designed for versatility, enabling ongoing use for in-depth forecasts.

Key Features

  • Customizable Financial Inputs: Adjust essential metrics such as revenue growth, EBITDA %, and capital investments.
  • Instant DCF Valuation: Quickly computes intrinsic value, NPV, and additional financial metrics.
  • High-Precision Accuracy: Leverages Enovis Corporation’s (ENOV) actual financial data for dependable valuation results.
  • Effortless Scenario Analysis: Easily evaluate various assumptions and analyze results side by side.
  • Efficiency Booster: Remove the hassle of constructing intricate valuation models from the ground up.

How It Works

  • Download: Obtain the ready-to-use Excel file featuring Enovis Corporation’s (ENOV) financial data.
  • Customize: Tailor forecasts, including revenue growth, EBITDA %, and WACC to your preferences.
  • Update Automatically: Watch as the intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various projections and instantly compare the results.
  • Make Decisions: Leverage the valuation findings to inform your investment strategy.

Why Choose the Enovis Corporation (ENOV) Calculator?

  • Accuracy: Utilizes real Enovis financials to ensure precise data.
  • Flexibility: Built for users to easily test and adjust inputs as needed.
  • Time-Saving: Avoid the complexities of creating a DCF model from the ground up.
  • Professional-Grade: Crafted with the expertise and precision expected at the CFO level.
  • User-Friendly: Designed for simplicity, making it accessible for those without extensive financial modeling skills.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and accurate valuation models for portfolio assessments related to Enovis Corporation (ENOV).
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within their organizations.
  • Consultants and Advisors: Deliver precise valuation insights for clients interested in Enovis Corporation (ENOV) stock.
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
  • Healthcare Industry Enthusiasts: Gain insights into how companies like Enovis Corporation (ENOV) are valued in the healthcare market.

What the Template Contains

  • Historical Data: Includes Enovis Corporation’s past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Enovis Corporation’s intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Enovis Corporation’s financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.